Itron, Inc. (ITRI)

Nasdaq Information Technology Electronic Equipment & Instruments S&P SmallCap 600
$98.44
-1.02 (-1.03%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+2.7%
1M+16.9%
3M-4.1%
6M+20.2%
YTD+6.0%
1Y-8.1%
3Y+73.2%
5Y+26.6%

Key statistics

Full financials →
Market cap$4.3B
P/E (TTM)15.9
EPS (TTM, diluted)$6.18
P/S1.86
P/B2.54
EV / EBITDA13.1
Revenue (TTM)$2.32B
Revenue growth-3.6%
Net margin12.1%
ROE16.5%
Debt / equity0.93
FCF yield8.5%
Dividend yield—
Payout ratio—
Beta (1Y)1.18
Volatility (1Y)40.6%
52-week range$77.77 – $108.20
Avg volume (50D)656.92K

Revenue & net income — last 8 quarters

Statements →
Oct 27, 8:35 AM ET

Itron Q3 revenue rises 3% to $599 million; GAAP EPS $1.61, non-GAAP $1.94

Positive earnings 2.02

Itron reported third-quarter 2026 revenue of $599 million, up 3% from a year earlier, with GAAP diluted EPS of $1.61 versus $1.41 and non-GAAP diluted EPS of $1.94 versus $1.54. The company also gave fourth-quarter and updated full-year 2026 outlooks, with full-year revenue expected between $2.37 billion and $2.385 billion and non-GAAP diluted EPS between $6.72 and $6.82, while free cash flow fell $18 million to $96 million.

  • Q3 2026 revenue $599 million, up 3%; annual recurring revenue $423 million, up 25%
  • GAAP diluted EPS $1.61 (up $0.20); non-GAAP diluted EPS $1.94 (up $0.40)
  • Q4 2026 outlook: revenue $621 million to $636 million; non-GAAP diluted EPS $1.70 to $1.80
  • Free cash flow $96 million in Q3, down $18 million; total backlog $4.3 billion at quarter end
Read the filing on SEC.gov ↗
Jul 28, 8:35 AM ET

Itron Q2 revenue falls 7% to $563 million; full-year earnings outlook raised

Mixed earnings Written later 2.02

Itron reported second quarter 2026 revenue of $563 million, down 7% from a year earlier, and GAAP diluted EPS of $1.19, down from $1.47. The company raised its full-year 2026 earnings outlook, with non-GAAP diluted EPS now expected between $6.30 and $6.50, while revenue guidance is $2.37 to $2.41 billion, so shareholders get higher earnings expectations alongside lower reported sales and profit.

  • Q2 2026 revenue was $563 million, down 7%, mainly due to lower Networked Solutions revenue, which fell 17%.
  • GAAP net income attributable to Itron was $53 million, or $1.19 per diluted share, versus $68 million, or $1.47, in Q2 2025; non-GAAP diluted EPS was $1.59 versus $1.62.
  • Updated full-year 2026 outlook: revenue of $2.37 to $2.41 billion and non-GAAP diluted EPS of $6.30 to $6.50; Q3 2026 outlook is revenue of $590 to $600 million and non-GAAP diluted EPS of $1.50 to $1.60.
Read the filing on SEC.gov ↗
Apr 28, 8:35 AM ET

Itron Q1 2026 revenue falls 3% to $587 million; GAAP EPS down to $1.18

Negative earnings Written later 2.02

Itron reported first-quarter 2026 revenue of $587 million, down 3% from a year earlier, as portfolio optimization and project timing reduced sales. GAAP diluted EPS fell to $1.18 from $1.42, and non-GAAP diluted EPS fell to $1.49 from $1.52, though adjusted EBITDA rose 5% to $92 million and free cash flow rose to $79 million. For the second quarter of 2026, Itron guided to revenue of $560 million to $570 million and non-GAAP diluted EPS of $1.25 to $1.35.

  • Q1 2026 revenue was $587 million, down 3%; Networked Solutions revenue fell 13% and Outcomes revenue rose 22%.
  • GAAP net income attributable to Itron was $53 million, or $1.18 per diluted share, versus $65 million, or $1.42, a year earlier.
  • Adjusted gross margin rose to 40.7% from 35.8%; free cash flow was $79 million, up from $67 million.
  • Q2 2026 outlook: revenue of $560 million to $570 million and non-GAAP diluted EPS of $1.25 to $1.35.
Read the filing on SEC.gov ↗
Feb 26, 4:15 PM ET

Itron prices upsized $700.0 million convertible notes offering due 2032

Neutral financing Written later 1.012.033.028.01

Itron entered into a purchase agreement to sell $700.0 million of 0.00% convertible senior notes due March 15, 2032 in a private offering, and the initial purchasers exercised in full an option for an additional $105.0 million on February 24, 2026. The notes have an initial conversion price of about $123.77 per share, a premium of about 30.0% over the $95.21 closing price on February 23, 2026, and the company paid about $92.8 million for capped call transactions meant to reduce dilution. Shareholders face possible dilution if the notes convert, though the capped calls offset some of that exposure up to a cap price of $190.42 per share.

  • Principal: $700.0 million initial notes plus $105.0 million option exercised in full on February 24, 2026; the notes pay no regular interest.
  • Initial conversion price of about $123.77 per share, a 30.0% premium to the $95.21 closing price on February 23, 2026.
  • Capped call transactions cost about $92.8 million, with a cap price of $190.42 per share.
  • Company expects to use net proceeds to pay for the capped calls, repurchase about $100.0 million of common stock, and repay its 0.00% convertible notes due 2026.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Recent SEC filings

EDGAR ↗

Famous investors who own ITRI

All investors →
InvestorValue% of portfolioLast quarter
George Soros Soros Fund Management $98.46M1.21% Added
Renaissance Technologies $30.91M0.04% Reduced

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Insider transactions

All insider trades →
DateInsiderTypeSharesPriceValue
Nov 03Wright David Marshall
VP, Corp. Controller & CAO
Sell1.33K$99.63$132.51K
Oct 29Wright David Marshall
VP, Corp. Controller & CAO
Gift2.46K—$0
Oct 01Savage Sheri
Director
Award608—$0
Oct 01Perez Santiago
Director
Award608—$0
Oct 01Mirchandani Sanjay
Director
Award608—$0
Oct 01Leyden Timothy M
Director
Award243—$0
Oct 01Lande Jerome J.
Director
Award608—$0
Oct 01Jaehnert Frank M
Director
Award608—$0
Oct 01Drury Scott D.
Director
Award608—$0

Prices are end-of-day and split-adjusted. Financial data from Itron, Inc.'s SEC XBRL filings. Not investment advice.